Drugs by alphabet:   A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

E Prescription Drug Pharmacy » Contact us Contact Us Name Email Message

ACP, ACP Foundation Diabetes Initiative Plans For 2 More Years
The Diabetes Initiative of the American College of Physicians (ACP) and the ACP Foundation released new information on the first three years of its project to improve diabetes care primarily through special efforts targeting physicians’ practices.The Initiative was funded in 2005 by an unrestricted educational grant from Novo
ACP, ACP Foundation Diabetes Initiative Plans For 2 More Years...

International Diabetes Federation Grant Supports Diabetes Screening And Prevention Program In Vietnam
The International Diabetes Federation (IDF) BRIDGES translational research grant program will fund a pilot study in Vietnam to increase opportunities for screenings for people at high-risk for getting type 2 diabetes and promote a program designed to motivate people to develop a healthy lifestyle.The National Hospital of Endocrinology
International Diabetes Federation Grant Supports Diabetes Screening And Prevention Program In Vietnam...

Antibiotics Not Always Best Bet For Battling Childhood Ear Infections
With cold and flu season right around the corner, many new parents of infants and toddlers will soon be visiting their family pediatrician complaining of painful or recurring ear aches. In most cases, children suffering from ear infections are prescribed Amoxicillin or a similar antibiotic to combat
Antibiotics Not Always Best Bet For Battling Childhood Ear Infections...

Tweens Double Use Of Diabetes Drugs
America’s tweens more than doubled their use of type-2 diabetes medications between 2002 and 2005, with girls between 10 and 14 years of age showing a 166 percent increase. The likely cause: Obesity, which is closely associated with Type 2 diabetes. [click link for full article] More: continued
Tweens Double Use Of Diabetes Drugs...

Isis Highlights Robust Drug Portfolio For Diabetes And Obesity At ADA Conference
Isis Pharmaceuticals, Inc. (Nasdaq: ISIS) announced the presentation of new preclinical data showing that antisense drugs potently reduce levels of sodium dependent glucose transporter type 2 (SGLT2), a key component in controlling glucose re-absorption in the kidney and the target of ISIS 388626. In addition, Isis presented
Isis Highlights Robust Drug Portfolio For Diabetes And Obesity At ADA Conference...

Drug-free Answer To The Relief From Snoring
With the onset of a new year, the time for resolutions is here once again. Many people are evaluating their lifestyles and behaviors, looking to make positive changes in their health and fitness routines. Often overlooked is the important role of quality sleep and its effect on one’s
Drug-free Answer To The Relief From Snoring...